Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4270366 | The Journal of Sexual Medicine | 2013 | 14 Pages |
Abstract
The present study demonstrated that on-demand T+PDE5i is a potentially promising treatment for women with HSDD, particularly in women with low sensitivity for sexual cues. Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, and Tuiten A. Toward personalized sexual medicine (part 2): Testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med 2013;10:810-823.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Saskia MD, Jos MSc, Kim MD, Irwin MD, PhD, Jeroen MSc, Diana MSc, Frederiek MD, Meredith PhD, Walter PhD, Hans MD, PhD, Berend PhD, Adriaan PhD,